Tag: Nattopharma

Lesaffre has acquired NattoPharma, a Norwegian nutraceutical company specializing in research and marketing of vitamin K2, in order to strengthen its presence in the...

The Norwegian Research Council has awarded a grant to NattoPharma to fund a four-year project to document the effects of calcium metabolism in the...

NattoPharma’s International Research Network, coordinated by the Cardiovascular Research Institute at Maastricht University (CARIM), has been awarded a second prestigious grant funded by the...

NattoPharma’s International Research Network has received the ITN research grant from European Commission’s research program Horizon 2020. Coordinated by Queen Mary University of London, other...

Cureus has published a new study that explores the extent that vitamin K2 deficiency is tied to cardiovascular disease (CVD). The results showed that...

A high intake of menaquinones (vitamin K2) was associated with a reduced risk of coronary heart disease, at least in hypertensive participants, while high...

A high intake of menaquinones (vitamin K2) was associated with a reduced risk of peripheral arterial disease (PAD; at least in hypertensive participants), according...

NattoPharma ASA has been awarded a patent that claims that MK-7 inhibits or reduces the incidence of age-related hardening of the arteries in individuals...

A study published in the Journal of Medicinal Food has tested and confirmed the role of vitamin K2 as MK-7 (menaquinone-7; MenaQ7 provided by...

NattoPharma says a study proving MenaQ7 Vitamin K2´s cardiovascular benefits has published in Thrombosis and Haemostasis. In the study titled Menaquinone-7 Supplementation Improves Arterial Stiffness...